Sheng Yu
Zhengzhou, 450008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Re: Health-related quality of life in patients with newly diagnosed advanced ovarian cancer receiving maintenance olaparib plus bevacizumab (PAOLA-1/ENGOT-ov25).
Journal: Journal of the National Cancer Institute
Published: May 08, 2026
Letter to the Editor Regarding "Datopotamab Deruxtecan Plus Pembrolizumab With or Without Platinum-Based Chemotherapy for Advanced or Metastatic NSCLC: The Phase Ib TROPION-Lung02 Trial".
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: April 11, 2026
RE: Clinician- and facility-level factors associated with chemotherapy dose reductions in stages I-IIIA breast cancer.
Journal: Journal of the National Cancer Institute
Published: March 19, 2026
Leveraging immune checkpoint inhibitors in lung cancer patients with pre-existing autoimmune disease: clinical insights, optimal timing, and predictive biomarkers for optimal treatment outcomes.
Journal: Frontiers in immunology
Published: December 04, 2024
Depression decreases immunity and PD-L1 inhibitor efficacy via the hypothalamic-pituitary-adrenal (HPA) axis in triple-negative breast cancer.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: April 15, 2024
Case report: sequential use of almonertinib based on the EGFR exon 20 insertion mutation achieves long-term control for advanced non-small cell lung cancer patients.
Journal: Translational cancer research
Published: December 06, 2021
HLA loss of heterozygosity-mediated discordant responses to immune checkpoint blockade in squamous cell lung cancer with renal metastasis.
Journal: Immunotherapy
Published: November 26, 2020
Evolution of Lung Cancer in the Context of Immunotherapy.
Journal: Clinical Medicine Insights. Oncology
Published: May 13, 2020
Upregulation of IBSP Expression Predicts Poor Prognosis in Patients With Esophageal Squamous Cell Carcinoma.
Journal: Frontiers in oncology
Published: August 09, 2019
Next-generation Sequencing Identified a Novel WDPCP-ALK Fusion Sensitive to Crizotinib in Lung Adenocarcinoma.
Journal: Clinical lung cancer
Published: January 30, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026